From Name:
From Email:
To Name:
To Email:

Optional Message:

Bevacizumab prolongs survival in advanced cervical cancer

from USA Today

The drug bevacizumab helps women with advanced cervical cancer live nearly four months longer, according to a new study that's predicted to change the standard of care for the disease. Women who combined bevacizumab and chemotherapy lived a median of 17 months after diagnosis, while those who received chemo alone lived 13.3 months, according to a study of 452 women in the New England Journal of Medicine. Just two decades ago, women with advanced cervical cancer lived only eight or nine months, says lead author Krishnansu Tewari, a professor of gynecologic oncology at the University of California Irvine Medical Center. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063